While the oncogenic potential of c-SRC is widely accepted, we discuss here emerging novel mechanisms by which deregulated HCK activity contributes to tumor initiation and progression, including gene amplification and the interaction with regulatory phosphatases and upstream receptor tyrosine kinases. This evidence concerns the gene SRC and neoplasm.